Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-11-15 Sale | 2024-11-19 4:08 pm | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Chief Scientific Officer | 15 | $478.56 | $7,178 | 25,813 (Direct) | View |
| 2024-05-15 Sale | 2024-05-17 4:22 pm | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Chief Scientific Officer | 54 | $430.93 | $23,270 | 25,813 (Direct) | View |
| 2024-02-26 Sale | 2024-02-27 4:24 pm | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO | 4,239 | $425.7 | $1,804,542 | 25,813 (Direct) | View |
| 2024-02-21 Sale | 2024-02-23 4:10 pm | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO | 3,002 | $421.77 | $1,266,154 | 34,022 (Direct) | View |
| 2024-02-20 Sale | 2024-02-21 4:13 pm | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO | 4,002 | $420.79 | $1,684,002 | 37,024 (Direct) | View |
| 2024-02-12 Sale | 2024-02-13 4:46 pm | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO | 3,145 | $420.24 | $1,321,655 | 47,588 (Direct) | View |
| 2023-11-15 Sale | 2023-11-17 4:11 pm | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO | 19 | $369.92 | $7,028 | 32,038 (Direct) | View |
| 2023-08-09 Sale | 2023-08-11 4:05 pm | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO | 63 | $345.51 | $21,767 | 32,038 (Direct) | View |
| 2023-02-27 Sale | 2023-02-28 4:40 pm | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO | 4,238 | $287.51 | $1,218,449 | 32,038 (Direct) | View |
| 2023-02-21 Sale | 2023-02-22 4:25 pm | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO | 4,002 | $293.77 | $1,175,676 | 40,246 (Direct) | View |
| 2023-02-14 Sale | 2023-02-16 4:11 pm | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO | 6,398 | $298.7 | $1,911,108 | 47,998 (Direct) | View |
| 2023-02-13 Sale | 2023-02-14 4:49 pm | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO | 4,798 | $298.9 | $1,434,126 | 54,396 (Direct) | View |
| 2023-02-06 Sale | 2023-02-08 4:53 pm | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO | 1,304 | $306 | $399,022 | 68,645 (Direct) | View |
| 2022-11-15 Sale | 2022-11-17 4:08 pm | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO | 34 | $308.61 | $10,493 | 36,077 (Direct) | View |
| 2022-11-07 Sale | 2022-11-09 4:40 pm | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO | 1,303 | $303.04 | $394,859 | 37,381 (Direct) | View |
| 2022-08-08 Sale | 2022-08-10 4:06 pm | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO | 1,304 | $292.54 | $381,469 | 38,684 (Direct) | View |
| 2022-07-19 Sale | 2022-07-21 4:48 pm | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO | 17,865 | $288.65 | $5,156,730 | 39,988 (Direct) | View |
| 2022-02-25 Sale | 2022-02-28 5:18 pm | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO | 7,572 | $230.98 | $1,748,990 | 36,077 (Direct) | View |
| 2022-02-18 Sale | 2022-02-22 4:51 pm | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO | 4,312 | $230.97 | $995,949 | 49,687 (Direct) | View |
| 2022-02-14 Sale | 2022-02-16 4:05 pm | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO | 2,444 | $232.02 | $567,057 | 57,438 (Direct) | View |
| 2022-02-11 Sale | 2022-02-14 4:11 pm | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO | 2,297 | $235.02 | $539,837 | 59,882 (Direct) | View |
| 2022-02-02 Sale | 2022-02-03 4:06 pm | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO | 4,660 | $251.47 | $1,171,842 | 65,697 (Direct) | View |
| 2021-11-15 Sale | 2021-11-16 4:04 pm | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO | 34 | $187.22 | $6,365 | 33,589 (Direct) | View |
| 2021-05-17 Sale | 2021-05-19 4:02 pm | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO | 79 | $216.36 | $17,093 | 33,589 (Direct) | View |
| 2021-02-25 Sale | 2021-02-26 4:03 pm | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO | 3,028 | $213.39 | $646,139 | 33,589 (Direct) | View |
| 2021-02-18 Sale | 2021-02-19 4:05 pm | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO | 7,825 | $211.83 | $1,657,590 | 39,033 (Direct) | View |
| 2021-02-11 Sale | 2021-02-16 4:02 pm | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO | 5,283 | $210.54 | $1,112,274 | 53,098 (Direct) | View |
| 2020-11-16 Sale | 2020-11-18 4:10 pm | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO | 38 | $223.47 | $8,492 | 28,902 (Direct) | View |
| 2020-08-06 Sale | 2020-08-10 4:13 pm | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO | 1,223 | $271.19 | $331,663 | 36,240 (Direct) | View |
| 2020-08-03 Sale | 2020-08-05 4:14 pm | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO | 2,330 | $278.24 | $648,290 | 33,562 (Direct) | View |
| 2020-05-15 Sale | 2020-05-19 4:21 pm | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO | 82 | $284.37 | $23,318 | 28,902 (Direct) | View |
| 2020-05-12 Sale | 2020-05-14 4:17 pm | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO | 1,304 | $287.33 | $374,678 | 43,240 (Direct) | View |
| 2020-05-06 Sale | 2020-05-08 4:17 pm | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO | 1,222 | $272.66 | $333,195 | 37,463 (Direct) | View |
| 2020-05-04 Sale | 2020-05-06 4:17 pm | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO | 2,330 | $260.86 | $607,803 | 35,892 (Direct) | View |
| 2020-02-25 Sale | 2020-02-26 4:29 pm | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO | 3,028 | $233.41 | $706,776 | 28,902 (Direct) | View |
| 2020-02-18 Sale | 2020-02-19 4:31 pm | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO | 3,128 | $243.67 | $762,201 | 34,346 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-23 Tax Withholding | 2024-02-27 4:24 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO | 3,970 | $431.79 | 25,813 (Direct) | View |
| 2024-02-16 Tax Withholding | 2024-02-21 4:13 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO | 3,750 | $424.01 | 37,024 (Direct) | View |
| 2024-02-20 Tax Withholding | 2024-02-21 4:13 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO | 2,812 | $420.58 | 37,024 (Direct) | View |
| 2024-02-09 Tax Withholding | 2024-02-13 4:46 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO | 2,099 | $422.74 | 47,588 (Direct) | View |
| 2024-02-06 Option Award | 2024-02-08 4:10 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO | 20,794 | $0 | 52,832 (Direct) | View |
| 2023-02-24 Tax Withholding | 2023-02-28 4:40 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO | 3,970 | $289.12 | 32,038 (Direct) | View |
| 2023-02-17 Tax Withholding | 2023-02-22 4:25 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO | 3,750 | $292.85 | 40,246 (Direct) | View |
| 2023-02-13 Tax Withholding | 2023-02-14 4:49 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO | 5,990 | $298.26 | 54,396 (Direct) | View |
| 2023-02-10 Tax Withholding | 2023-02-14 4:49 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO | 3,461 | $294.33 | 54,396 (Direct) | View |
| 2023-02-06 Exercise | 2023-02-08 4:53 pm | N/A 2029-02-05 | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO | 1,304 | $0 | 68,645 (Direct) | View |
| 2023-02-06 Exercise | 2023-02-08 4:53 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO | 1,304 | $187.53 | 68,645 (Direct) | View |
| 2023-02-01 Option Award | 2023-02-03 4:30 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO | 32,568 | $0 | 68,645 (Direct) | View |
| 2022-11-07 Exercise | 2022-11-09 4:40 pm | N/A 2029-02-05 | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO | 1,303 | $0 | 37,381 (Direct) | View |
| 2022-11-07 Exercise | 2022-11-09 4:40 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO | 1,303 | $187.53 | 37,381 (Direct) | View |
| 2022-08-08 Exercise | 2022-08-10 4:06 pm | N/A 2029-02-05 | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO | 1,304 | $0 | 38,684 (Direct) | View |
| 2022-08-08 Exercise | 2022-08-10 4:06 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO | 1,304 | $187.53 | 38,684 (Direct) | View |
| 2022-07-19 Exercise | 2022-07-21 4:48 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO | 7,338 | $155.57 | 39,988 (Direct) | View |
| 2022-07-19 Exercise | 2022-07-21 4:48 pm | N/A 2029-02-05 | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO | 17,765 | $0 | 39,988 (Direct) | View |
| 2022-07-19 Exercise | 2022-07-21 4:48 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO | 10,427 | $187.53 | 39,988 (Direct) | View |
| 2022-02-24 Tax Withholding | 2022-02-28 5:18 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO | 6,038 | $227.86 | 36,077 (Direct) | View |
| 2022-02-17 Tax Withholding | 2022-02-22 4:51 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO | 3,439 | $232.51 | 49,687 (Direct) | View |
| 2022-02-10 Tax Withholding | 2022-02-14 4:11 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO | 3,518 | $237.74 | 59,882 (Direct) | View |
| 2022-02-02 Exercise | 2022-02-03 4:06 pm | N/A 2027-02-02 | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO | 4,660 | $86.52 | 65,697 (Direct) | View |
| 2022-02-01 Option Award | 2022-02-03 4:06 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO | 32,108 | $0 | 65,697 (Direct) | View |
| 2021-02-24 Tax Withholding | 2021-02-26 4:03 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO | 2,416 | $217.57 | 33,589 (Direct) | View |
| 2021-02-17 Tax Withholding | 2021-02-19 4:05 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO | 6,240 | $211.75 | 39,033 (Direct) | View |
| 2021-02-10 Tax Withholding | 2021-02-12 4:02 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO | 2,974 | $214.16 | 58,381 (Direct) | View |
| 2021-02-03 Option Award | 2021-02-05 4:42 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO | 32,453 | $0 | 61,355 (Direct) | View |
| 2020-08-06 Exercise | 2020-08-10 4:13 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO | 1,223 | $155.57 | 36,240 (Direct) | View |
| 2020-08-06 Exercise | 2020-08-10 4:13 pm | N/A 2028-02-05 | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO | 1,223 | $0 | 36,240 (Direct) | View |
| 2020-08-03 Exercise | 2020-08-05 4:14 pm | N/A 2027-02-02 | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO | 2,330 | $0 | 33,562 (Direct) | View |
| 2020-08-03 Exercise | 2020-08-05 4:14 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO | 2,330 | $86.52 | 33,562 (Direct) | View |
| 2020-05-12 Exercise | 2020-05-14 4:17 pm | N/A 2029-02-05 | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO | 1,304 | $0 | 43,240 (Direct) | View |
| 2020-05-12 Exercise | 2020-05-14 4:17 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO | 1,304 | $187.53 | 43,240 (Direct) | View |
| 2020-05-06 Exercise | 2020-05-08 4:17 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO | 1,222 | $155.57 | 37,463 (Direct) | View |
| 2020-05-06 Exercise | 2020-05-08 4:17 pm | N/A 2028-02-05 | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO | 1,222 | $0 | 37,463 (Direct) | View |
| 2020-05-04 Exercise | 2020-05-06 4:17 pm | N/A 2027-02-02 | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO | 2,330 | $0 | 35,892 (Direct) | View |
| 2020-05-04 Exercise | 2020-05-06 4:17 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO | 2,330 | $86.52 | 35,892 (Direct) | View |
| 2020-02-24 Tax Withholding | 2020-02-26 4:29 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO | 2,416 | $239.23 | 28,902 (Direct) | View |
| 2020-02-17 Tax Withholding | 2020-02-19 4:31 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO | 2,496 | $241.5 | 34,346 (Direct) | View |